Harald Hampel Selected Research

Prodromal Symptoms

9/2020	Biomarkers for Alzheimer's Disease (AD) and the Application of Precision Medicine.
1/2019	Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases.
1/2017	Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease.
12/2016	Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease.
3/2016	Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study.
12/2011	The future of Alzheimer's disease: the next 10 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harald Hampel Research Topics

Disease

217	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2002
76	Dementia (Dementias) 01/2022 - 02/2002
71	Cognitive Dysfunction 10/2022 - 08/2003
35	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2004
26	Atrophy 01/2022 - 05/2005
10	Disease Progression 01/2021 - 10/2002
9	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 01/2004
8	Neuroinflammatory Diseases 01/2021 - 09/2007
7	Amyloid Plaque 12/2011 - 04/2003
6	Parkinson Disease (Parkinson's Disease) 11/2020 - 08/2006
6	Prodromal Symptoms 09/2020 - 12/2011
4	Brain Diseases (Brain Disorder) 01/2021 - 12/2011
4	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2020 - 08/2003
4	Tauopathies 11/2019 - 02/2006
3	Mental Disorders (Mental Disorder) 11/2021 - 04/2011
3	Amyloidosis 01/2021 - 04/2017
3	Neurobehavioral Manifestations 01/2018 - 12/2011
3	Inflammation (Inflammations) 05/2013 - 01/2008
2	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 08/2017
2	Nervous System Diseases (Neurological Disorders) 01/2018 - 02/2013
2	Corticobasal Degeneration 08/2017 - 01/2016
2	Cerebral Cortical Thinning 12/2016 - 12/2011
2	Schizophrenia (Dementia Praecox) 09/2012 - 12/2011
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2008 - 08/2003
2	Down Syndrome (Down's Syndrome) 04/2004 - 10/2003
1	Autism Spectrum Disorder 11/2021
1	Genetic Risk Score 01/2021
1	Synucleinopathies 01/2021
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 11/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2020
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 11/2020
1	Huntington Disease (Huntington's Disease) 11/2020
1	Ataxia (Dyssynergia) 11/2020
1	Cardiovascular Abnormalities 01/2020
1	Neoplasms (Cancer) 01/2019
1	Proteostasis Deficiencies 12/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2017
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 08/2017

Drug/Important Bio-Agent (IBA)

144	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2002
63	Amyloid (Amyloid Fibrils)IBA 10/2022 - 04/2003
30	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
24	Apolipoproteins E (ApoE)IBA 01/2022 - 12/2005
22	tau Proteins (tau Protein)IBA 01/2021 - 08/2002
21	Amyloid beta-PeptidesIBA 01/2016 - 08/2002
20	Biological ProductsIBA 11/2021 - 01/2009
17	Pharmaceutical PreparationsIBA 01/2021 - 02/2002
15	Cholinergic Agents (Cholinergics)IBA 01/2022 - 03/2003
12	ApolipoproteinsIBA 12/2020 - 12/2005
11	Threonine (L-Threonine)FDA Link 10/2012 - 08/2002
10	Peptides (Polypeptides)IBA 01/2015 - 12/2002
8	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2021 - 09/2003
7	EnzymesIBA 11/2021 - 09/2003
7	Donepezil (Aricept)FDA LinkGeneric 01/2017 - 01/2006
5	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2018 - 10/2003
4	SynucleinsIBA 01/2022 - 12/2018
4	NeurograninIBA 01/2021 - 01/2017
4	Indicators and Reagents (Reagents)IBA 01/2017 - 01/2011
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
3	LipidsIBA 09/2019 - 12/2011
3	LithiumIBA 01/2019 - 06/2009
3	Apolipoprotein E4IBA 01/2012 - 06/2010
3	Protons (Proton)IBA 12/2011 - 11/2005
3	Atrial Natriuretic Factor (ANF)IBA 07/2011 - 06/2009
3	Serine (L-Serine)FDA Link 01/2010 - 08/2003
3	amyloid beta-protein (1-42)IBA 06/2009 - 08/2002
3	AntibodiesIBA 09/2003 - 08/2002
2	LigandsIBA 01/2020 - 12/2011
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 02/2003
2	Pemetrexed (MTA)FDA Link 12/2017 - 07/2008
2	CalciumIBA 03/2017 - 09/2011
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2014 - 10/2011
2	Natriuretic PeptidesIBA 07/2011 - 04/2011
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2011 - 01/2010
2	Cholinesterases (Cholinesterase)IBA 03/2010 - 09/2007
2	Galantamine (Galanthamine)FDA LinkGeneric 03/2010 - 04/2009
2	Amino Acids FDA Link 05/2007 - 08/2002
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 08/2005 - 02/2003
1	antineoplaston A10 (A 10)IBA 01/2022
1	NeuregulinsIBA 11/2021
1	sharpinIBA 01/2021
1	Synaptotagmins (Synaptotagmin)IBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 12/2020
1	ProgranulinsIBA 01/2020
1	N- dimethyl- 2,2- diphenyl- 3- furanmethanamine hydrochloride tetrahydro-NIBA 01/2020
1	Biological FactorsIBA 10/2019
1	Lithium ChlorideIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Fluspirilene (Imap)IBA 02/2018
1	peptide IIBA 01/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2018

Therapy/Procedure

28	Therapeutics 01/2022 - 03/2002
12	Precision Medicine 01/2021 - 01/2017
4	Activities of Daily Living (ADL) 01/2020 - 01/2006
2	Immunotherapy 01/2014 - 04/2003
2	Secondary Prevention 07/2013 - 04/2006
1	Drug Therapy (Chemotherapy) 01/2018